TLRY - Cannabis stocks lead weekly healthcare gainers ahead of fresh legalization move

Marijuana players dominated top performers in healthcare this week ahead of a Republican-led attempt for federal legalization of cannabis in the U.S. Meanwhile, less than favorable quarterly earnings hurt decliners. However, the healthcare stocks ended the week in positive territory with a ~0.6% gain to become the second-best performing sector in the S&P 500, narrowly beating the ~0.3% drop in the broader index. Among stocks with more than $2B market capitalization and over 100K average daily volume over the past five sessions, Canopy Growth (NASDAQ:CGC) surged the most with a ~29.5% gain. Its local rivals, Aurora Cannabis (NASDAQ:ACB) and Tilray (NASDAQ:TLRY), were not far behind, rising ~27.6% and ~20.9%, respectively to group among the top five performers. The resurgence of cannabis players comes at a time Global X Cannabis ETF (NASDAQ:POTX) and AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) remain sharply lower from their February peak and precedes the launch of a Republican bill on Monday to

For further details see:

Cannabis stocks lead weekly healthcare gainers ahead of fresh legalization move